Market regulation · 04/05/2022

Analysis of Agreement Containing Consent Orders To Aid Public Comment

Hikma Pharmaceuticals PLC/Custopharm, Inc. has reached a consent agreement to settle allegations of violating federal law on unfair competition methods. The attached analysis explains the allegations and proposed consent orders in the agreement.